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Abstract
Perinatal hypoxia-ischemia is a major cause of acute mortality in newborns and cognitive and motor impairments in
children. Cerebral hypoxia-ischemia leads to excitotoxicity and necrotic and apoptotic cell death, in which mitochondria
play a major role. Increased resistance against major damage can be achieved by preconditioning triggered by subtle
insults. CO, a toxic molecule that is also generated endogenously, may have a role in preconditioning as low doses can
protect against inflammation and apoptosis. In this study, the role of CO-induced preconditioning on neurons was
addressed in vitro and in vivo. The effect of 1 h of CO treatment on neuronal death (plasmatic membrane permeabilization
and chromatin condensation) and bcl-2 expression was studied in cerebellar granule cells undergoing to glutamate-induced
apoptosis. CO’s role was studied in vivo in the Rice-Vannucci model of neonatal hypoxia-ischemia (common carotid artery
ligature +75 min at 8% oxygen). Apoptotic cells, assessed by Nissl staining were counted with a stereological approach and
cleaved caspase 3-positive profiles in the hippocampus were assessed. Apoptotic hallmarks were analyzed in hippocampal
extracts by Western Blot. CO inhibited excitotoxicity-induced cell death and increased Bcl-2 mRNA in primary cultures of
neurons. In vivo, CO prevented hypoxia-ischemia induced apoptosis in the hippocampus, limited cytochrome c released
from mitochondria and reduced activation of caspase-3. Still, Bcl-2 protein levels were higher in hippocampus of CO pre-
treated rat pups. Our results show that CO preconditioning elicits a molecular cascade that limits neuronal apoptosis. This
could represent an innovative therapeutic strategy for high-risk cerebral hypoxia-ischemia patients, in particular neonates.
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Introduction
Perinatal hypoxia-ischemia (HI) remains a major cause of acute
mortality in newborns and of cognitive and motor impairments in
children [1]. Cerebral damage results from oxygen and tissue
energy depletion that lead to: acidosis, inflammation, glutamate
excitotoxicity, cell death and generation of reactive oxygen species
(ROS) during reperfusion [2]. Cerebral hypoxia-ischemia induces
distinct types of cell death: within the ischemic core, rapid cell death
occurs mainly as necrosis; while in the penumbra, the region around
the ischemic core, delayed apoptotic cell death takes place hours
and days after the insult, contributing to secondary damage [3]. In
the developing brain, apoptosis also plays a homeostatic role, and
many pro-apoptotic factors are normally up-regulated during early
stages of maturation [4,5]. Therefore, apoptosis is closely related to
the injury response after hypoxia-ischemia in the immature brain
of newborn infants [6]. Mitochondria play a major role in death of
mammalian cells [7]. During the apoptotic process and upon
mitochondrial membrane permeability, several biochemical mol-
ecules confined to the inter-membrane space are released to the
cytosol thus activating proteases and nucleases. For example,
cytochrome c released from mitochondria interacts with apoptotic
protease activating factor 1 (Apaf-1) and caspase-9 to form the
apoptosome that activates caspase-3 leading to cell death [8].
Currently, hypothermia is the only treatment used clinically for
minimizing cerebral damage after perinatal hypoxia-ischemia, but
it has limited efficiency and its use has also limitations [9]. Other
therapies, which either can be used alone or in combination with
hypothermia, are therefore needed. Preconditioning (PC) induc-
tion consists of an insult that does not cause damage, but triggers a
protective state (tolerance) that increase cellular resistance against
a subsequent and more severe challenge [10,11]. PC can induce
an early response (minutes or hours) or a late response within days
including de novo protein synthesis [12]. Furthermore, clinical
studies with patients suffering from transient ischemic attacks
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(TIA) [13] and animal models [12,14,15] have suggested that
cerebral tolerance induced by a PC state is an efficient strategy to
protect brain tissue against HI. Thus, preconditioning processes
are promising alternatives for therapy in patients at high risk of
suffering HI. Indeed, perinatal HI may eventually be predicted
based on known risk factors associated with previous ischemic
episodes including intrauterine fetal distress and hypoxic-ischemic
insults during birth [16]; Bonifacio et al. 2011). Also, PC-based
therapies could be useful for neonates going through major heart
surgery with associated risks of global cerebral ischemia
[10,13,17].
Carbon monoxide (CO) is commonly known to be toxic. This is
due to its high affinity for haem-proteins, which can compromise
oxygen delivery to tissues (carboxy-haemglobin) or can decrease
oxidative phosphorylation at the cellular level by binding to
cytochrome c oxidase [18]. CO is an endogenous molecule
generated by haem-oxygenase (HO) activity along with the
production of free iron and biliverdin [19]. Low doses of
exogenous CO are cytoprotective against inflammation and
apoptosis, in particular following cardiovascular incidents, organ
rejection and autoimmune disease in several models [19]. Also, in
rat retinal ganglion cells, inhalation of 250 ppm of CO protected
against ischemia-reperfusion injury [20]. In the central nervous
system (CNS), low amounts of CO limit neuroinflammation in a
model of multiple sclerosis [21] and induced vasodilation,
presenting cytoprotective effects in the cerebral circulation in a
model of epileptic seizures in newborn piglets [22]. CO treatment
also decreased infarct volume and brain damage in adult models of
transient and permanent focal cerebral ischemia when the animals
were exposed to CO immediately after middle cerebral artery
occlusion [23,24]. Nevertheless, the cellular mechanisms involved
in CO-induced neuroprotection are still not fully understood. In
primary cultures of cerebellar neurons, CO triggers precondition-
ing and prevents apoptosis by ROS signaling and modulation of
soluble guanylyl cyclase, nitric oxide synthase and mitochondrial
ATP dependent potassium channel [25]. Likewise, in primary
cultures of astrocytes, CO inhibits apoptosis by directly targeting
mitochondria and preventing their membrane permeabilization,
which is also dependent on ROS and protein glutathionylation
signaling [26].
Since preconditioning emerges as a promising strategy to limit
brain damage following perinatal ischemia, we have examined the
ability of CO to induce preconditioning and to limit apoptosis in
the hippocampus in the present study. Pre-treatment of rat pups
with CO prevented hippocampal cell death via: an increase on Bcl-
2 expression, a decrease on cytochrome c translocation from
mitochondria into cytosol and an inhibition of caspase-3
activation. To our knowledge, this is the first study to use CO
preconditioning to prevent hypoxia-ischemia-induced neuronal
death in the developing brain.
Materials and Methods
In vitro experiments
Materials. All chemicals were purchased from Sigma-Al-
drich (Munich, Germany) unless stated otherwise. Plastic tissue
culture dishes were from Nunc (Roskilde, Denmark); fetal bovine
serum (FBS), glutamine, penicillin-streptomycin solution and
Dulbecco’s Minimum Essential Medium (DMEM) were obtained
from Gibco (Paisley, UK). CO 100% was purchased as
compressed gas (Linde, Germany).
Cell Cultures. Primary cerebellar granule cells were pre-
pared as described by Schousboe [27] from Wistar rats purchased
from Instituto de Higiene e Medicina Tropical (Lisboa, Portugal).
Briefly, cells were isolated from postnatal day 7(P7) rat cerebella,
after mild trypsinization followed by trituration in a DNase
solution containing soybean trypsin inhibitor. Cells were suspend-
ed (16106 cells/mL) and cultured in BME basal medium
containing 12 mM glucose, 7.3 mM p-Aminobenzoic acid, 4 mg/
L insulin, 2 mM glutamine, 1% (vol/vol) penicillin-streptomycin
solution and 10% (vol/vol) FBS. Cells were cultured in 24- and 96-
well poly-D-lysine coated plates and maintained in humidified
atmosphere of 7% CO2 at 37uC. To prevent glia proliferation,
cytosine arabinoside (20 mM) was added 48 h after seeding. The
experiments were performed on 1-week-old cerebellar granule
neuronal culture. All experiments were performed at least in
triplicate.
Preparation of CO solutions. Fresh stock solutions of CO
gas were prepared each day and sealed. Phosphate-buffered saline
(PBS) was saturated by bubbling 100% of CO gas for 30 minutes
to produce a 1023 M stock solution. The concentration of CO in
solution was determined spectrophotometrically by measuring the
conversion of deoxymyoglobin to carbon monoxymyoglobin, as
described by Motterlini (Motterlini 2002).
Cell treatments, induction of apoptosis and assessment of
apoptosis-associated parameters. Neuronal cells were cul-
tured on poly-D-lysine-coated coverslips. Neuronal apoptosis was
induced immediately after the end of CO exposure with 10 to
30 mM of glutamate over a 24 h period to mimic excitotoxicity,
which is a consequence of cerebral ischemia [25]. For inhibition of
cell death, cerebellar granule cells were treated with 10 mM CO
for 1 h prior to glutamate addition. Neurons were stained with
Hoechst 33342 (2 mM, Sigma) and Propidium Iodide (PI, 1 mM,
Molecular Probes, USA) followed by quantitative assessment of
chromatin condensation and cell viability, respectively. Cells were
observed on a Leica DMRB microscope using a filter with a
bandpass of 340–380 nm (UV).
Real Time Quantitative PCR. After 6 or 24 h of CO
treatment, RNA was extracted from primary cerebellar neurons
(36106 cells) using the High Pure RNA isolation Kit (Roche,
Germany); cDNA was synthesized from RNA (Transcriptor High
Fidelity cDNA Synthesis Kit, Roche, Germany). For real time
quantitative PCR (RT-qPCR), forward and reverse primer
sequences specific for bcl-2 gene consisted of 59-GGTGGAG-
GAACTCTTCAGGG-39 and 59-GAGACAGCCAGGA-
GAAATCA-39, respectively. An internal control used expression
of cyclophilin A, a constitutive protein, using forward and reverse
sequences: 59-ATGGCAAATGCTGGACCAAA-39 and 59-
GCCTTCTTTCACCTTCCCAAA-39. The RT-qPCRwas per-
formed according to manufacturer indications (LightCyclerH
FastStart DNA MasterPLUS SYBR Green I, Roche Diagnostics,
Germany). Amplification used the following protocol: denatur-
ation at 95uC for 10 minutes; amplification for 35 cycles, at 95uC
for 15 seconds, 60uC for 6 seconds, 72uC for 15 seconds with a
single fluorescent measurement; 95uC for 15 seconds, 60uC for
15 seconds, 95uC for 15 seconds with a continuous fluorescence
measurement for the melting curve; finally the cooling step was at
40uC. The results were expressed in percentage relative to the
control sample.
In vivo experiments
Animals. P4–P7 (postnatal day 4 to postnatal day 7) Wistar
rat pups (n = 74, Janvier, France) weighing on average 27 (61,4)
and 35 g (61,5) respectively were used. Great differences in pup’s
weight are due to the fast rate of growing at this period of life. All
animal experimental procedures were carried out in strict
accordance with the recommendations in the European Commu-
nity Council Directive 86/609/EEC (November 24, 1986),
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authorization 17/2010-B (June 30, 2010) by Italian Ministry of
Health and University of Turin institutional guidelines on animal
welfare (law 116/92 on Care and Protection of Living Animals
Undergoing Experimental or Other Scientific Procedures). The
protocol was approved by Turin University Bioethical Committee.
Animals were given ad libitum access to food and water and kept on
12h:12h light/dark cycle. Pup’s sex was not taken into account,
and male and female pups were used randomly for introducing
variability in the study and for being more representative of
relevant patient populations. All efforts were made to minimize
suffering and limit the number of animals used.
Experimental plan. To test whether CO prevented HI-
induced neurodegeneration, and to ensure that CO administration
did not cause toxicity, animals were randomly assigned to four
experimental groups: CONTROL group (sham surgery without
hypoxia exposure, n = 22), CO+SHAM group (CO exposure prior
to sham surgery without hypoxia exposure, n = 16), HI group
(hypoxia-ischemia, n= 17) and CO+HI group (CO exposure prior
to HI, n = 19) (Fig. 1). Animals were randomly assigned to each
group through computer-generated (Excel) randomization sched-
ules before performing any experimental procedure. During the
HI procedure and CO exposure pups in all experiment groups
were kept separate from their mother the equal period of time.
Rats were sacrificed 6 and 24 hours after HI onset. All subsequent
procedures were done by researchers who were blinded to the
experimental groups.
Carbon monoxide exposure. Because this is the first study
of CO as neuroprotective agent against perinatal ischemia, using
rat pups, CO exposure conditions (dose and time) were
extrapolated from several previous in vivo studies for liver [28],
[29], heart [30] or adult brain [24]. To induce a preconditioning
state and test the neuroprotective role of CO, rat pups were
exposed to 250 ppm of CO for 1 h at P4, P5 and P6. During the
exposure, gas concentration was carefully monitored by a CO
analyser (Interscan, Chatsworth, US) and temperature was kept at
37uC. At the end of each CO administration, rat pups were
returned to their cages. During CO exposure time, control pups
(without CO exposure) were also kept separated from their
mothers.
Model of neonatal cerebral hypoxia-ischemia. HI was
induced in P7 rat pups, according to the Rice-Vannucci
modification of the Levine procedure [31,32]. The P7 rat was
chosen because its level of cortical development closely resembles
that of 32–34 week gestation: cortical layering is complete and low
grade myelination is visible [33]. Rat pups were anesthetized with
isoflurane (Isoflurane Vet, Alcyon Italia, Marene, Italy, 4% during
induction, then maintained with 2.5%), presented in a mixture of
30:70 O2/N2O, delivered with a face-mask throughout the
surgery. Through a mid-neck incision, the left common carotid
artery (CCA) was exposed and double-ligated by means of 4/0 silk
suture in order to permanently interrupt the blood flow. Care was
taken to avoid damage to the adjacent vagal nerve. The procedure
was completed in 10–15 min. After 2 h of recovery and feeding,
Figure 1. Experimental groups and time-points schematic representation. Control group, n= 22, untreated animals that did not suffer any
treatment; Carbon Monoxide (CO) group, n= 16, subjected to 3 exposures of 250 ppm, for 1 h at P4, P5 and P6; Hypoxia-Ischemia (HI) group,
n= 17, animals that underwent surgery and hypoxia (8% of O2 in nitrogen) exposure for 75 minutes; CO+HI group, n= 19, CO treatment plus
hypoxia-ischemia. Animals were euthanized at 6 and 24 h post-HI. Brains were collected and analyzed for lesion volume and cell death markers, as
described in the methods section. Histo, for brains analyzed by histological methods; WB, for brains collected and processed for western blot analysis.
doi:10.1371/journal.pone.0042632.g001
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pups were exposed to humidified 8% O2–92% N2 gas mixture
[34] for 75 minutes in a home-made acrylic hypoxic chamber
(2,7 L). During all surgical procedures and exposure in the
hypoxic chamber the body temperature of the pups was
maintained with a heating carpet. Pups were allowed to recover
for 5 min in room air, before returned to their mothers. Sham-
operated animals underwent the same surgical procedure without
CCA ligation and put into a similar chamber for the same period
of time as the HI group to mimic the time away from the mother.
The temperature was monitored and maintained at 37uC
throughout all procedure. Cell death assessment was performed
at 6 h and 24 h after HI, based on our in vitro experimental data
(data not shown, [25,26,35].
Tissue processing. For histological and immunohistochem-
ical staining, animals were deeply anesthetized by intraperitoneal
injection of chloral hydrate 24 h after surgery and transcardially
perfused with PBS, followed by buffered paraformaldehyde (4% in
0.1 M phosphate buffer, PB, pH 7.4). Brains were post-fixed
overnight in the same solution, infiltrated with 30% sucrose in
0.1 M PB for cryoprotection, frozen, and stored at 220uC.
50 mm-thick serial coronal sections were cut on the cryostat; every
sixth slice was mounted on gelatine-coated slides for histological
and immunological staining. For Western blot assays, animals
were decapitated and brains dissected in ice-cold water, kept in ice
for 15 min, and then frozen at 280uC.
Histological and immunohistochemical assessment. To
define ischemic boundaries and precisely identify apoptotic
profiles, serial sections were stained with cresyl violet. For
immunohistochemistry, sections were immersed in 10% normal
donkey serum (NDS), then incubated overnight in antibodies
against cleaved-caspase 3 (1:200, Cell Signaling Technology,
Beverly, MA, US), S100b (1:1000, Sigma-Aldrich) or Ki67 (1:400,
Novocastra, Newcastle, UK) at 4uC; primary antibodies were
prepared in 10% NDS solution. For Ki67 immunohistochemistry,
sections were initially heated in 0.01 M citrate buffer (pH 6.0) for
3 minutes at 800 W using a microwave oven prior to primary
antibody incubation to enhance antigen retrieval. Cy2- or Cy3-
conjugated anti-rabbit or anti-mouse secondary antibodies (1:200
and 1:400 respectively, 2 h at room temperature, Jackson
ImmunoResearch Laboratories, West Grove, USA) were used to
visualize binding of primary antibodies; cell nuclei were counter-
stained with 49,69-diamidino-2-phenylindole (DAPI, Sigma-Al-
drich). Control tissue was processed as above with non-immune
serum instead of the primary antibody. Immunoreacted sections
were examined with Nikon 90i epifluorescence microscope by an
investigator blinded to the experimental groups. Co-localization
was determined on a Leica TCS SP5 confocal laser scanning
microscope equipped with argon 488 nm, helium–neon 543 nm,
and helium–neon 633 mn lasers. Double-immunolabeled cells
were analyzed using three-dimensional (3D) reconstructed images
with the x–z and y–z orthogonal projections, using Leica LAS AF
software.
Stereological counts in the hippocampus. Cresyl violet-
stained sections were analysed with 1006 oil-immersion objective
for stereological estimation of apoptotic profiles. Sections were
visualized using a Nikon Eclipse E600 microscope equipped with a
motorized stage controller; they were photographed with a CCD
camera (OptronicsMicrofire, Goleta, CA, USA). Analyses were
done by an investigator blinded to the experimental groups. We
used the optical fractionator method for stereological estimates of
apoptotic profiles in the hippocampal formation; the volume of
hippocampus was calculated according to the Cavalieri’s principle
(Neurolucida 8.0 User’s Guide—Document Version NL0108-
08.10 Microbrightfield Inc., 1988–2008.); all analyses were done
with use of StereoInvestigator (Microbrightfield, Williston, VT,
USA). Series were 300 mm spaced; the first section of each series
was dorsal to the hippocampal white matter; subsequent collected
sections were equidistant from this reference slice; each series
consisted of 9 sections. The procedure yields a series of
systematically random sections (a requirement for the optical
fractionator methods, Lyster et al 2005; West et al 1991).
Stereological sampling was done according to Fitting (Fitting
et al., 2008). An initial pilot study optimized the sampling scheme.
The coefficient of sampling error (CE) was calculated to determine
the appropriate number and size of disector counting frames.
When considering 9 sections per case, a sampling grid of
4006400 mm, with a 25625 mm counting frame and a disector
height of 20 mm (disector volume = 12500 mm3) was chosen; the
CE varied between 0.01 and 0.1. To avoid oversampling, two
guard zones were set on top and bottom of sections, each
corresponding to 10% of the focally measured section thickness.
Only neurons bearing morphological changes strongly suggestive
for apoptosis, namely cell shrinkage, chromatin condensation and
visible apoptotic bodies were considered dying cells and counted.
The estimated total (T) number of objects (i.e., apoptotic profiles)
was finally calculated in accordance to the following formula, as
previously described by Fitting [36]
T~SQ x t=h x1=asfx1=ssf
where SQ is the number of objects counted in the disectors, t is the
section thickness, h is the height of disector probe, asf is the ratio
between counting frames area and grid step along x and y axis,
and ssf is the section sampling fraction and was set to 1/6. To
avoid bias due to asymmetrical cutting, the total estimated number
of objects was then normalized to the sampled volume and density
values are presented (Fig. S1).
Immunoblotting. The apoptotic hall-markers: (i) Bcl-2
expression, (ii) release of cytochrome c from mitochondria and
(iii) caspase activation, were assessed in hippocampus isolated 6
and 24 h after the insult. Rat pups were first anesthetized then
decapitated, the hippocampus dissected and stored at 280uC until
analysis; tissue was triturated manually with Potter Elvehjem in
lysis buffer (15 mMTris-HCl, pH 7.6, 320 mM sucrose, 1 mM
DTT, 1 mM MgCl2, 0.5% protease inhibitor, 3 mM EDTA-K,
30 mg/mL CsA). For total cell extract analysis, samples were
sonicated before protein quantification. For mitochondrial anal-
ysis, this protein extract was centrifuged at 800 g for 10 min at
4uC, supernatant was re-centrifuged at 9200 g for 15 min at 4uC
and the pellet containing mitochondria was stored for Western
blot analysis. Protein content (from total extract or mitochondrial
fraction) was determined by BCA assay (Pierce, Illinois). Proteins
(20–40 mg) were separated on SDS-PAGE (12% polyacrylamide),
transferred to PVDF membranes, blocked in 5% skim milk in Tris-
buffered saline (containing 0.1% of Tween 20) for 1 h at room
temperature. Equal amounts of protein were confirmed by the
internal control assessment of ß-actin. The following primary
antibodies were used overnight at 4uC: anti-Bcl-2 (Santa Cruz
Biotechnology, 1:5000); anti-cytochrome c (Abcam, 1:2000); anti-
active caspase-3 (Cell Signaling, 1:5000); anti ß-actin (Santa Cruz
Biotechnology, 1:5000); all were diluted in blocking solution. Blots
were developed using the ECL chemiluminescence kit (Amersham
Bioscience, UK) after incubation with HRP-labeled anti-mouse or
anti-rabbit IgG (GE Healthcare, UK, 1:5000) for 1 hour at RT.
The area and intensity of bands were quantified by densitometry
analysis (GraphPad Prism 4), and were normalized to the positive
control (100%). Each experiment was repeated three times, and
gave similar results.
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Statistical analysis of data. All experiments were carried
out at least in triplicate; values are mean 6 SD, n$3. Error bars,
corresponding to standard deviation. Statistical comparisons were
performed using ANOVA: single factor with replication, with
P,0.05, n$3. P,0.05 means that samples are significantly
different at a confidence level of 95%. All statistical comparisons
were conducted using the SPSS package (version 18, SPSS Inc.,
Chicago, IL, USA). For in vivo study, data distribution and equality
of variances were initially assessed by the Shapiro-Wilk [37]and
the Levene median [38] tests, respectively. One-way ANOVA was
applied to determine overall significant differences in the number
of apoptotic cells among groups. Post-hoc analyses were conducted
when p,0.05 by Fisher’s protected least significant difference
(PLSD) test.
Results
Carbon monoxide prevents excitotoxicity-induced cell
death and induces Bcl-2 expression in primary cultures of
neurons
Primary cultures of neurons were pre-treated for 1 h with CO-
saturated solution at 10 mM. After 24 h, chromatin condensation
and loss of membrane integrity were assessed by fluorescence
microscopy (representative photos in Fig. 2A), and CO partially
prevented neuronal cell death (Fig. 2B). Additionally, Bcl-2 mRNA
was measured by RT-Q-PCR, with increased expression levels at
6 h and 24 h (Fig. 2C) after CO treatment; which is in accordance
with CO-related neuroprotection, since Bcl-2 is an anti-apoptotic
protein.
Figure 2. Effect of carbon monoxide treatment on neuronal apoptosis. (A) Representative micrographs of neurons treated or not with
20 mM of glutamate and 10 mM of CO. Apoptotic hallmarks were analyzed by fluorescent microscopy. Upper panel, for the photos taken with the filter
for phase contrast, middle panel, for Hoechst (white arrows for nuclei with condensed chromatin) and lower panel, for propidium iodide (white arrows
for cells which membrane integrity was lost). (B) Primary cultures of neuronal cells were pre-treated with 10 mM CO, followed by 24 h of glutamate
(10–30 mM) treatment. Cell viability was assessed by counting cells containing normal nuclei and plasmatic membrane integrity. For each coverslip, at
least 1500 cells were counted. All values are mean6 SD (error bars), n = 5; *p,0.05 compared to control. (C) The effect of 10 mM CO treatment on Bcl-
2 expression was assessed by its mRNA quantification.
doi:10.1371/journal.pone.0042632.g002
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Effect of preconditioning on HI-induced apoptosis in vivo
75 min of hypoxic exposure after carotid occlusion (perinatal
model for cerebral hypoxia-ischemia) reliably induced mild
damage in terms of cell death in the subregions of the
hippocampus (Fig. 3A–E), predominantly at the level of CA2
and CA3 ipsilateral to the CCA occlusion, while the cortex did not
show any detectable damage. The cytoarchitecture was partly lost
due to shrinkage relative to the contralateral side, in which
histological morphology was preserved (Fig. 3A–E). A great
number of apoptotic profiles were detected at the level of CA1,
CA2/3 and dentate gyrus (DG) after HI. Early stages of the
apoptotic cascade were revealed by the presence of cells with
darkly stained nuclei, condensed chromatin and dense cytoplasm
(pyknosis); late stages of apoptosis were also visible in cells that had
DNA fragmentation, and nuclei broken into several discrete
chromatin bodies (karyorrhexis), cytoplasmic disruption, and
appearance of apoptotic bodies (Fig. 3C–E). The density of
apoptotic cells was significantly higher in the hippocampus
ipsilateral to the occlusion (ischemic side) compared to the
contralateral (intact) side, both in the HI group and the CO+HI
group (Fig. 3F). However, the density of apoptotic profiles in the
ischemic hemisphere was efficiently reduced (64%) in the CO+HI
group compared to the HI group (Fig. 3F).
Figure 3. Carbon monoxide effect in hippocampus after perinatal hypoxia-ischemia – apoptotic profiles. Whereas contralateral
hippocampus displayed a preserved morphology (A) following HI, diffuse tissue disruption was detected in the hippocampus ipsilateral to the
occlusion (B). C–E are representative pictures of ischemic hippocampus, where diffuse apoptosis was documented; with peculiar morphological
features including pyknotic nuclei (C), indicating early stage of apoptosis, progressive nuclear fragmentation (D) and karyorrhexis as confirmed by
detectable apoptotic bodies (E). Compared to HI group, the number of apoptotic profiles was significantly lower when animals were exposed to CO
prior to HI (F). All values are mean 6 SD (error bars); *p,0.05 compared to Control group for the corresponding side and **p,0.05 compared to HI
group ischemic hippocampus. (G) For each group there is no significant difference in cytotoxic edema volume (mm3) between the ipsi- and the
contralateral hippocampus.
doi:10.1371/journal.pone.0042632.g003
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Cytotoxic edema, known to contribute to early ischemic
damage, may represent a confounding factor in estimating cell
density and, when severe, may lead to an underestimation of
apoptosis. However, this was not the case in our material: no
ischemia-related differences in hippocampal volumes (mm3)
between the hemispheres were seen in any of the groups
(Fig. 3G). Similarly, the volume of ischemic or intact hippocampus
did not significantly vary between groups. Accordingly, active
caspase 3 positive cells were predominantly detected in CA2, CA3
and DG regions of the hippocampus in the HI group (Fig. 4A–C),
whereas fewer immunolabeled cells were visible in the CO+HI
group (Fig. 4D–F) and none were detected in CO+SHAM group
(Fig. 4G–I). No significant differences were detected between the
HI and CO+HI group with regard to glial activation and cell
proliferation as assessed by S100b and Ki67 immunohistochem-
istry, respectively (data not shown).
Effect of Carbon Monoxide on expression of apoptotic
markers
The results of immunoblots for apoptotic markes in total cellular
extracts of ipsilateral (IL) and contralateral (CL) hippocampus or
in mitochondria-enriched fractions are shown in Fig. 5. CO pre-
treatment lead to an increased expression of anti-apoptotic protein
Bcl-2 at 6 and 24 h in both hemispheres compared to the HI
group. At 24 h, Bcl-2 expression among CO pre-treated pups was
also higher than control pups (Fig. 5A). These data are in
accordance with cell death prevention by CO in hippocampus and
validate the in vitro results showing higher levels of Bcl-2 mRNA for
CO-treated neurons (Fig. 2C). Therefore, CO appears to trigger
tissue preconditioning and to stimulate cell survival, by changing
gene expression, such as bcl-2. Cytochrome c levels in mitochon-
dria-enriched fraction of hippocampus of the HI group were lower
at 6 h than at 24 h after the insult relative to controls. At both 6
and 24 h after HI, CO pre-treated rat pups had higher levels of
cytochrome c than the HI group in mitochondria-enriched
fraction of hippocampus (Fig. 5B). Thus, CO prevented
cytochrome c release from mitochondria, which can limit
apoptosome formation and caspase-3 activation. Indeed, cas-
pase-3 activation was less pronounced in IL hippocampal extracts
from CO+HI group than from HI group at 6 and 24 h, while
caspase-3 activation was similar in CL CO+HI and HI groups
(Fig. 5C).
Discussion
Two complementary approaches were applied to demonstrate
the neuroprotective role of carbon monoxide: in vitro excitoxicity
induction in primary culture of rat cerebellar neurons and an in
vivo model of perinatal ischemia in rat pups. In primary neuronal
cultures, 1 h of CO pre-treatment had a positive outcome on the
survival of neurons against excitotoxic-induced cell death and
Figure 4. Carbon monoxide effect in hippocampus after perinatal hypoxia-ischemia – cleaved caspase 3 expression. Low (scale
bar = 100 mm) magnification CLSM photographs of the hippocampus of HI (A, B), CO-HI (C, D) and CO sham operated (E, F) rat pups. In blue, DAPI-
stained nuclei; in red, cleaved caspase 3-positive cells. Caspase 3-positive profiles following HI were particularly frequent in CA1–2 and in the dentate
gyrus, and were decreased in number following CO preconditioning. CO preconditioning alone did not induce caspase 3 activation in sham operated
animals.
doi:10.1371/journal.pone.0042632.g004
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increased expression of the anti-apoptotic gene bcl-2 (Fig. 2).
Likewise, prior exposure to CO significantly reduced the number
of apoptotic profiles in the hippocampus (by 64%) 24 h following
hypoxia-ischemia in rat pups (Fig. 3).
Apoptotic factors are up-regulated in early stages of brain
development and play a major role in brain damage following
perinatal ischemia because apoptosis is a key cellular process
during CNS development [39,40]. Therefore, apoptotic hallmarks
were assessed in vivo. Indeed, CO pre-treatment improved the
cellular anti-apoptotic machinery (Fig. 4 and 5). In accordance
with the in vitro data, increased Bcl-2 expression was found in
hippocampal extracts from CO-treated pups (Fig. 5A). Further-
more, increase in Bcl-2 expression activates many anti-apoptotic
pathways and indicates that late preconditioning might be
involved in CO neuroprotection [41]. Accordingly, previous
studies have reported that protein synthesis is required for CO-
conferred neuroprotection [25] and mitochondrial biogenesis
stimulation is also involved in CO’s apoptosis inhibition [35].
Thus, CO cytoprotection might be related to late preconditioning
induction, although further studies are necessary. Nevertheless,
Figure 5. Effect of carbon monoxide on apoptotic markers in hippocampal extracts after 6 and 24 h of HI – protein expression and
sub-cellular localization. Representative immunoblots (upper panels) and the corresponding quantifications, as relative percentages to the
hippocampus from control rat pups (lower panels). (A) Bcl-2 expression in total hippocampal extracts. All values are mean 6 SD (error bars), n = 3;
*p,0.05 compared to HI group for the corresponding side and **p,0.05 compared to HI group ipsilateral hippocampus. (B) Cytochrome c levels in
enriched mitochondrial fraction from hippocampus, which is an indirect way for measuring cytochrome c release. All values are mean 6 SD (error
bars), n = 3; *p,0.05 compared to HI group hippocampus for the corresponding side. (C) Caspase-3 activation in total extracts. All values are mean6
SD (error bars), n = 3; *p,0.05 compared to HI group for the ipsilateral hippocampus.
doi:10.1371/journal.pone.0042632.g005
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early preconditioning responses cannot be excluded from CO’s
mode of action, since ROS signaling is involved in CO-induced
cytoprotection [19,26,42], which presents new hypotheses for
further studies based on cerebral cell anti-oxidant defense.
In hippocampus, higher cytochrome c levels in mitochondria
were found with CO pre-treatment (Fig. 5B). This indicates a
reduced release of cytochrome c from mitochondria, which can be
related to the reported direct action of CO on mitochondrial
membrane permeabilization [26]. Still, the increased cytochrome
c sequestration in the mitochondria contributes to the lower levels
of caspase-3 activation found in hippocampus from CO pre-
treated pups (Fig. 5C). Furthermore, in hippocampal CA2, CA3
and DG regions, activated caspase-3 positive cell populations
decreased when pups were exposed to CO before the hypoxic-
ischemic insult (Fig. 4). An active role of CO in cerebral apoptosis
prevention in vivo has been suggested by other authors: (i) HO-1
knockout mice exhibit a larger volume of tissue damage following
injection of NMDA compared to wild type mice [43], and (ii)
Zeynalov and colleagues report that low doses of exogenous CO
protect against transient or permanent focal ischemia in adult mice
[23,24].
Perinatal HI can be partially predicted based on the presence of
several risk factors: signals of distress during intrauterine life and
hypoxic-ischemic insults at birth (Bonifacio et al. 2011). Also,
preterm newborns represent a high-risk population for brain injury
due to HI [44]. Therefore, preconditioning-based strategies can
become potential therapies for perinatal HI, and CO is a
promising candidate. Other preconditioning-based strategies have
also been developed for perinatal cerebral ischemia. In piglets, 3 h
of exposure to 8% oxygen prior to hypoxia/ischemia insult
induced neuroprotection via up-regulation of hypoxia-inducible
factor-1a (HIF-1a) and vascular endothelial factor (VEGF) [45].
Similarly, in adult mice, preconditioning by exposure to hypoxia
and isoflurane presented a neuroprotective effect [46]. In an
experimental model of HI similar to ours (left carotid artery
ligation and 90 minutes of 8% O2), hydrogen has shown to be
neuroprotective by blocking apoptosis [47]. Finally, lithium pre-
treatment prevented apoptotic and autophagic neuronal cell death
in the hippocampus following neonatal HI [48].
CO may be a useful therapeutic adjunct. In fact, other
inhalation therapies have been introduced in clinics [49], to
reduce toxicity resulting from the metabolization of administered
drugs, since drug extraction occurs by exhalation. The therapeutic
application of nitric oxide (NO) as vasodilator in several disease
models and also in injured lungs of premature and newborn babies
is now widely accepted [50]. NO is chemically similar to CO.
However, unlike CO, NO reacts rapidly with molecular oxygen
and produces peroxynitrite (ONOO2), which is highly reactive.
Likewise, noble gases have also been studied for medical
applications, especially xenon [51]. Recently, Ryang and co-
workers [52] described the efficacy of argon in protecting rat
brains in a model of transient middle cerebral artery occlusion.
Taken all together, potential CO-inhaled based therapy has the
added value of integrating two critical advantages: it is chemically
inert compared to NO and is an endogenous molecule compared
to noble gases [17].
To overcome a possible systemic CO toxic effect, the use of
CO-releasing molecules (CORM’s) has been proposed [53]. These
small organic and organometallic compounds are able to deliver
CO in a timely and tissue-specific manner. This permits a
significant reduction in carboxyhaemoglobin formation and
toxicity, which opens novel windows of opportunity for clinical
applications. The biological activities of CORMs include cardio-
protection in isolated perfused rat heart, protection in acute
hepatic reperfusion injury in rats, endothelial cells protection
during cold preservation, and injury impairment in the case of HI
injury during kidney transplantation, among others [19,54]. Very
recently, CORM-3 was shown to modulate the inflammatory
response and to reduce brain damage in an adult rat model of
hemorrhagic stroke [55], indicating that CORM-3 can cross the
blood brain barrier.
Altogether, in vitro and in vivo approaches have demonstrated
that CO initiates a cascade of events that prevents neuronal
apoptosis: (i) increase of Bcl-2 expression, (ii) prevention of
cytochrome c release from mitochondria, (iii) inhibition of
caspase-3 activation and (iv) decrease of chromatin condensation.
CO administration induced late preconditioning and limited
hippocampal neuronal cell death following cerebral perinatal
ischemia. In conclusion, the biological neuroprotective role of CO,
coupled with the possibility of using CORMs, opens avenues of
further research and potential applications of CO-based therapies
in cerebral ischemic models. Moreover, this innovative approach
takes advantage of an endogenous molecule (CO) and intracellular
pathways (preconditioning) for limiting neuronal cell death.
Supporting Information
Figure S1 Stereological measurement of apoptosis. To
estimate apoptosis, the hippocampal formation was traced in serial
sections under 46magnification, then counts were performed at
1006magnification (A); to allow unbiased sampling, counting sites
were randomly selected by software at the end of tracing
procedures (B). Each subsequent section was then superimposed
and aligned to this reference slice to allow unbiased 3D-
reconstruction of the hippocampus (C–D).
(PDF)
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